2024年和2023年发表SCI论文情况汇总
时间: 2025-06-27  作者:   浏览次数: 10

序号

年度

论文题目

第一作者

通讯作者

发表期刊、卷期号

影响因子(2024

1

2024

OMP38 of Carbapenem-Resistant Acinetobacter Baumannii-Mediated mtDNA Release Activates the cGAS-STING Signaling to Induce Inflammatory Response.

杨洋

黄建安、刘泽毅

Adv Sci (Weinh). 2024 Dec 4;12(4):e2408292.

14.1

2

2024

CD73 promotes non-small cell lung cancer metastasis by regulating Axl signaling independent of GAS6.

朱健洁、杜雯雯、曾园园

刘泽毅、黄建安

Proc Natl Acad Sci U S A. 2024 Oct 22;121(43):e2404709121.

9.1

3

2024

Diosmin reduces the stability of Snail and Cyclin D1 by targeting FAK to inhibit NSCLC progression.

麻晨康、但梦霞

刘泽毅、李建军

Phytomedicine. 2024 Dec;135:156135.

8.3

4

2024

N6-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing.

王安祺、曾园园

黄建安、刘泽毅

ell Mol Biol Lett. 2024 Aug 2;29(1):106.

10.2

5

2024

Isotoosendanin exerts anti-tumor effects in NSCLC by enhancing the stability of SHP-2 and inhibiting the JAK/STAT3 pathway.

舒陈影、陈昱灵、吴正艳

刘泽毅、闫兆威

Phytomedicine. 2024 Sep;132:155832.

8.3

6

2024

Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.

吴正艳、焦敏、舒陈影

刘泽毅、朱晔涵

Cell Commun Signal. 2024 Jun 6;22(1):313.

8.9

7

2024

Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting IFNα-TYK2-STAT-HSPA5 axis.

曾园园、赵健、吴正艳

刘泽毅、黄建安

NPJ Precis Oncol. 2024 Mar 23;8(1):74.

8

8

2024

Comprehensive analysis of Epha10 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in non-small cell lung cancer.

王安祺、朱健洁

刘泽毅、黄建安

Sci Rep. 2024 Aug 23;14(1):19623.

3.9

9

2024

CD274 (PD-L1) negatively regulates M1 macrophage polarization in ALI/ARDS.

汤娜娜、杨洋、谢逸菲

黄建安、刘泽毅

Front Immunol. 2024 Feb 19;15:1344805.

5.9

10

2023

FTO facilitates cancer metastasis by modifying the m6A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer.

高莉蓉、王安祺

黄建安、刘泽毅

Cell Commun Signal. 2023 Nov 2;21(1):311.

8.9

11

2023

Forkhead box L2 is a target of miR-133b and plays an important role in the pathogenesis of non-small cell lung cancer

李娟、高莉蓉、王安祺

季成、刘泽毅

Cancer Med. 2023 Apr;12(8):9826-9842.

3.1